Beam Therapeutics Inc 10-Q for FY2021 Q3
Beam Therapeutics Inc. (BEAM)
10-Q
2021-11-08
For: 2021-09-30
View Original
Added on
April 09, 2026
About this 10-Q
Beam Therapeutics Inc filed this 10-Q on November 8, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $763K
- up 12616.7% from $6000 a year earlier
- Net loss
- $28.12M
- compared with a net loss of $34.45M a year earlier
- Diluted EPS
- -$0.42
- compared with -$0.69 a year earlier